| 1. | ALA650616 | F | Inhibitory effect against HIV-2 replication in CEM /TK-(thymidine kinase deficient) cells. | Human immunodeficiency virus 2 | 22 | | organism-based format | Scientific Literature |
| 2. | ALA883261 | F | Inhibitory effect against HIV-2 replication in CEM cells. | Human immunodeficiency virus 2 | 29 | | organism-based format | Scientific Literature |
| 3. | ALA654977 | F | In vitro antiviral activity against HIV-2 (ROD) in CEM (human leukemia) cells. | Human immunodeficiency virus 2 | 22 | | organism-based format | Scientific Literature |
| 4. | ALA656273 | F | Inhibition of human immunodeficiency virus-2 (HIV-2) induced cytopathicity in CEM cells | Human immunodeficiency virus 2 | 19 | | organism-based format | Scientific Literature |
| 5. | ALA884267 | F | Inhibition of HIV-2 (ROD) nediated cytotoxicity in CEM (human leukemia) cells. | Human immunodeficiency virus 2 | 19 | | organism-based format | Scientific Literature |
| 6. | ALA654739 | F | Antiviral activity against HIV-2 virus infected CEM cell lines. | Human immunodeficiency virus 2 | 18 | | organism-based format | Scientific Literature |
| 7. | ALA656737 | F | In vitro inhibition of HIV-2 replication in human T-lymphocytic cells (CEM). | Human immunodeficiency virus 2 | 16 | | organism-based format | Scientific Literature |
| 8. | ALA656322 | F | Concentration of the required to protect CEM cells of Human T-lymphocyte against Cytopathogenicity of HIV-2 by 50% | Human immunodeficiency virus 2 | 15 | | organism-based format | Scientific Literature |
| 9. | ALA653878 | F | Effective concentration required to inhibit HIV-2 induced cytopathicity by 50% in CEM cells | Human immunodeficiency virus 2 | 20 | | organism-based format | Scientific Literature |
| 10. | ALA656773 | F | Inhibition of human immunodeficiency virus type 2 (HIV-2) induced cytopathogenicity in CEM cells | Human immunodeficiency virus 2 | 34 | | organism-based format | Scientific Literature |
| 11. | ALA656779 | F | In vitro inhibition of HIV-2(ROD) cytopathicity in CEM cells. | Human immunodeficiency virus 2 | 17 | | organism-based format | Scientific Literature |
| 12. | ALA677522 | F | Concentration required to inhibit HIV-2(G) induced cytopathicity in E6SM cells by 50% | Human immunodeficiency virus 2 | 9 | | organism-based format | Scientific Literature |
| 13. | ALA691926 | F | Compound was tested for antiviral activity against HIV-2 | Human immunodeficiency virus 2 | 6 | | organism-based format | Scientific Literature |
| 14. | ALA691114 | F | Concentration required to protect human T-lymphocytic cells against the cytopathogenicity of HIV-2 | Human immunodeficiency virus 2 | 69 | | organism-based format | Scientific Literature |
| 15. | ALA691115 | F | Effective concentration against cytopathicity of HIV-2 strain (ROD) in CEM cell line | Human immunodeficiency virus 2 | 8 | | organism-based format | Scientific Literature |
| 16. | ALA691116 | F | Effective concentration required to inhibit HIV-2 induced cytopathicity in CEM cell culture by 50%. | Human immunodeficiency virus 2 | 21 | | organism-based format | Scientific Literature |
| 17. | ALA691281 | F | Effective concentration required to inhibit HIV-2 induced cytopathicity in MT-4 cell culture by 50%. | Human immunodeficiency virus 2 | 22 | | organism-based format | Scientific Literature |
| 18. | ALA686835 | F | In vitro inhibitory activity against HIV-2 (ROD) HIV strain; NT ='Not active' | Human immunodeficiency virus 2 | 1 | | organism-based format | Scientific Literature |
| 19. | ALA686836 | F | Inhibitory activity against HIV-2 (ROD); NA ='Not active' | Human immunodeficiency virus 2 | 1 | | organism-based format | Scientific Literature |
| 20. | ALA686837 | F | Antiviral activity against HIV-2 infected with LAV-2 EHO | Human immunodeficiency virus 2 | 4 | | organism-based format | Scientific Literature |